Filing metadata

Accession number
0001209191-21-042811
Form type
Form 4
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Jun 23, 2021
Reporting period
Jun 21, 2021
Description
Insider transaction

Explore SEC Filings Hub